ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 711611 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 711611; 2) Community: the network communities that were significantly associated with the response to NSC 711611; 3) Molecule: the relationships between components within communities and NSC 711611; 4) MDR: the compounds that were significantly associated with the NSC 711611.

NSC Compound Enrichment Correlation
NSC 695329 Null 0.0462077035966088 0.010194346
NSC 676788 Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arabinopyranosyl] ester 0.0467178916101838 -0.15988092
NSC 698278 Null 0.0467178916101838 0.065083372
NSC 716679 Null 0.046717891610184 0.49598979
NSC 723001 Diethyl-N[4-(3-thienylquinoxalyn-2-yl)oxiphenylacetyl]-L-glu tamate 0.046717891610184 -0.31166634
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.046717891610184 0.36919955
NSC 735946 N-(4'-Hydroxy-3'-methoxycinnamoyl)-17a-aminomethyl-estra-1,3 ,5(10)-trien-3,17b-diol 0.046717891610184 0.54271537
NSC 756140 GSK1220512A 0.046717891610184 0.059126823
NSC 732661 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]i soquinoline 0.0467178916101842 0.048027581
NSC 174121 Methotrexate Derivative 0.0467178916101845 0.3088954
Total:163  Current:154    [First] [Prev] [Next] [Last]